Non-Hodgkin Lymphoma Archives - Cancer Therapy Advisor

ROPETAR failed to demonstrate any clinical benefit in alternating treatment with pazopanib and evero

Hepatosplenic T-cell Lymphoma: Recent Progress and Future Considerations

By

September 17, 2020

Researchers reviewed the clinical/pathologic aspects of HSTCL and summarized the latest molecular studies and potential novel therapeutic targets.

A patient discusses a new oral medication regimen.

Hematologic Cancers

Waldenström Macroglobulinemia Treated With Ixazomib Combination Therapy: Long-Term Follow-Up

By

Lauren Dembeck, PhD

September 10, 2020

Investigators measured ixazomib, dexamethasone, and rituximab combination treatment among patients with treatment-naive Waldenström macroglobulinemia.

Lymphoma

2021 Update on Diagnosis, Risk Stratification, and Management of Cutaneous B-Cell Lymphomas

By

Rita Aghjayan

September 9, 2020

Researchers assessed diagnosis, risk-stratification, and management of 3 distinct subgroups of primary cutaneous lymphomas.

Association Between Cabozantinib and Skin Reactions in Patients with Urothelial Carcinoma

Lymphoma

Managing Skin Flare Reactions in Patients Receiving Mogamulizumab for Cutaneous T-cell Lymphoma

By

Susan Moench, PhD, PA-C

September 9, 2020

Using a grading system for skin flare reactions increases potential for continuing administration of mogamulizumab despite the occurrence of this adverse effect.

Lymphoma

Targeted Therapy for Non-Hodgkin Lymphoma: Current Progress and Future Plans

By

Jessica Wapner

September 4, 2020

Novel immunotherapies and small molecule pathway inhibitors are transforming the standard of care for some of the most challenging lymphoma subtypes.

Computer artwork of HIV in the bloodstream.

Lymphoma

Survival Outcomes and HIV Status Among Patients With Plasmablastic Lymphoma

By

Jonathan Goodman, MPhil

August 24, 2020

Researchers studied clinical characteristics linked to overall survival and lymphoma-specific survival in patients with plasmablastic lymphoma.

A recent article is only the latest in a series of studies drawing attention to the importance of di

Hematologic Cancers

Improving Survival in Younger Patients With Waldenström Macroglobulinemia

By

Jonathan Goodman, MPhil

August 21, 2020

Researchers evaluated data from younger patients with Waldenström macroglobulinemia to determine features that predict outcomes in this patient population.

Hematologic Cancers

Development of a Tool to Predict Neurotoxicity Associated With CAR-T Therapy

By

Susan Moench, PhD, PA-C

August 18, 2020

The occurrence, severity, and need for treatment of cytokine release syndrome were key parameters in the assessment of CAR-T–related neurotoxicity risk.